Market Research Report
Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024
|Published by||Juniper Research Ltd||Product code||629484|
Delivery time: 1-2 business days
|Digital Therapeutics & Wellness: Disruption, Innovation Opportunities & Forecasts 2019-2024|
|Published: May 15, 2019||Content info:||
Juniper's new Digital Therapeutics & Wellness research provides an in-depth assessment of the evolving requirements, capabilities and market landscape of these disruptive technologies. This essential guide provides detailed analysis and forecasts for the following key segments:
The research includes:
Interviewed: 2Morrow, Akili Interactive Labs, Blue Mesa Health, Voluntis.
Case Studied: Calm, XpresSpa.
Included in Digital Therapeutics Disruptors & Challengers Quadrants: 2Morrow, Akili Interactive Labs, AppliedVR, Big Health, Blue Mesa Health, Brain Power, Canary Health, Click Therapeutics, Digital Therapeutics Inc, Ginger.io, Livongo, MapMyHealth, Meru Health, My mHealth, Nicotrax, Omada, Pacifica, Pear Therapeutics, Proteus, Silver Cloud, Tiatros, Vida Health, Virta Health, Voluntis, Welldoc, Wellthy Therapeutics.
Included in Digital Wellness Disruptors & Challengers Quadrant: 7Cups, Calm, Fitbit, GOQii, Headspace, Limeade, Mindapps, Onlife Health, Sleepace, Somnox, Spotlight Six Software, Stop, Breathe & Think, Welltok.
Aetna, Apple, AstraZeneca, Aura, Cigna, Digital Therapeutics Alliance, FDA, Flex Digital Health, Garmin, Glytec, Huawei, Humana, Insight Timer, International Diabetes Foundation, John Hancock, Kickstarter, Magellan Healthcare, Medullan, Mindbliss, myStrength, NHS, NICE, Otsuka, Peerfit, Propeller Health, Thrive Global, Vitality, World Bank, World Health Organisation.